Sleep Problem in Post COVID-19 Patient, Its Impact on Quality of Life and Current Management: An Evidence-based of Case Report

Hamzah Shatri, Rizka Zainudin, Yanuar Ardani, Edward Faisal, Rudi Putranto

Abstract


Background: COVID-19 is a global health problem that affects both physical and psychological aspect of patients. Sleep problems were experienced by many patients during the acute phase of after COVID-19 recovery. It affects patient’s quality of life and required comprehensive management. This evidence-based case report aims to study the effect of sleep disturbance on quality of life and what is the appropriate management in post COVID-19 patients. Methods: searching were conducted in Pubmed, Cohcrane, EBSCO according to clinical questions. Study was selected based on inclusion and exclusion criteria, then it was critically appraised. Results: high score on the insomnia severity index and the Pittsburgh sleep quality index were found to be associated with quality of life. Cognitive Behavioural Therapy is currently the best evidence-based treatment in patient during and after COVID-19. Conclusion: sleep disturbance is a problem that many post COVID-19 patient face and CBT can improve their quality of life.


Keywords


sleep problem; post COVID-19; quality of life; cognitive behavioral therapy

References


Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed [Internet]. 2020 [cited 2022 Mar 8];91(1):157–60. Available from: https://pubmed.ncbi.nlm.nih.gov/32191675/

WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. 2022 [cited 2022 Mar 8]. Available from: https://covid19.who.int/

Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr [Internet]. 2020 Sep 1 [cited 2022 Mar 8];14(5):779–88. Available from: https://pubmed.ncbi.nlm.nih.gov/32526627/

El Sayed S, Gomaa S, Shokry D, Kabil A, Eissa A. Sleep in post-COVID-19 recovery period and its impact on different domains of quality of life. Egypt J Neurol psychiatry Neurosurg [Internet]. 2021 Dec 1 [cited 2022 Mar 8];57(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34924750/

Choi EPH, Hui BPH, Wan EYF. Depression and anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health [Internet]. 2020 May 5 [cited 2022 Mar 8];17(10). Available from: https://pubmed.ncbi.nlm.nih.gov/32466251/

Saputra BD, Levita J, Mustarichie R. Efficacy, Safety, and Drug. Drug interactions for insomnia therapy in COVID-19 patients. J Multidiscip Healthc [Internet]. 2022 Jan 21 [cited 2022 Mar 8];15:137–52. Available from: https://www.dovepress.com/efficacy-safety-and-drugdrug-interactions-for-insomnia-therapy-in-covi-peer-reviewed-fulltext-article-JMDH

Becker PM. Overview of sleep management during COVID-19. Sleep Med [Internet]. 2021 [cited 2022 Mar 8]; Available from: /pmc/articles/PMC8106485/

Maramis MM. Pandemi COVID-19 dan ansietas. In: Sutrisno, Kalalo RT, Andrianto, editors. COVID-19 dan problematika kesehatan mental. Surabaya: Ikatan Dokter Indonesia Wilayah Jawa Timur; 2021. p. 73–104.

Wichniak A, Kania A, Siemiński M, Cubała WJ. Melatonin as a potential adjuvant treatment for COVID-19 beyond sleep disorders. Int J Mol Sci [Internet]. 2021 Aug 2 [cited 2022 Mar 8];22(16). Available from: https://pubmed.ncbi.nlm.nih.gov/34445329/

Khawam E, Khouli H, Pozuelo L. Treating acute anxiety in patients with COVID-19. Cleve Clin J Med [Internet]. 2020 May 14 [cited 2022 Mar 8];87(5):1–4. Available from: https://www.ccjm.org/content/early/2020/05/12/ccjm.87a.ccc016.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.